
Upbound Group (UPBD) shares have risen 5% in the past month, and analysts' mean price target of $36.63 suggests a potential 39.3% upside; however, the wide range of price targets and general skepticism around analyst forecasts warrant caution. Despite concerns about price target reliability, analysts' upward revisions to EPS estimates and Upbound's Zacks Rank #2 (Buy) suggest potential near-term gains, correlating with historical trends where positive earnings estimate revisions precede stock price increases.
Upbound Group (UPBD) shares have registered a 5% gain over the past four weeks, closing the last trading session at $26.29. Wall Street analysts' mean short-term price target of $36.63 suggests a potential upside of 39.3% for the stock. However, this mean estimate is derived from eight targets with a notable standard deviation of $8.07, and individual price targets range from a 1.1% decline to a 90.2% surge, indicating significant divergence in analyst expectations. While the article expresses skepticism about the reliability of price targets in general, it highlights a more compelling positive signal for UPBD: an upward trend in earnings estimate revisions. The Zacks Consensus Estimate for the current year has increased by 0.3% over the past month, reflecting one upward revision and no negative revisions. This, combined with UPBD's current Zacks Rank #2 (Buy), which signifies it is in the top 20% of over 4,000 ranked stocks, is presented as a more robust indicator of potential near-term stock price appreciation, supported by empirical research linking earnings estimate revisions to stock movements.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.50
Ticker Sentiment